Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study
Dupilumab appears to be safe and effective in AD patients with a broad range of hematologic comorbidities, including malignancies. These findings support its use in real-world settings, though prospective studies are warranted to further assess long-term safety in this population.
Authors
- Martina Maurelli (ORCID: https://orcid.org/0000-0001-7492-8010)
- Angelo Valerio Marzano (ORCID: https://orcid.org/0000-0002-8160-4169)
- Simone Ribero (ORCID: https://orcid.org/0000-0002-0098-1406)
- Giovanni Paolino (ORCID: https://orcid.org/0000-0002-3032-2217)
- Maddalena Napolitano (ORCID: https://orcid.org/0000-0003-3309-8190)
- Giampiero Girolomoni (ORCID: https://orcid.org/0000-0001-8548-0493)
- Mariateresa Rossi (ORCID: https://orcid.org/0000-0002-5101-159X)
- Niccolò Gori (ORCID: https://orcid.org/0000-0003-1987-0623)
- Laura Calabrese (ORCID: https://orcid.org/0000-0001-5238-2336)
- Enzo Errichetti (ORCID: https://orcid.org/0000-0002-7152-6136)
- Ilaria Trave (ORCID: https://orcid.org/0000-0002-5469-4517)
- Zeno Fratton (ORCID: https://orcid.org/0000-0002-7454-1999)
- Mario Bruno Guanti (ORCID: https://orcid.org/0000-0001-5303-3517)
- Dario Didona (ORCID: https://orcid.org/0000-0002-6119-1870)
- Giacomo Dal Bello (ORCID: https://orcid.org/0000-0002-5645-8403)
- Anna Balato (ORCID: https://orcid.org/0000-0001-5485-0172)
- Stefano Bighetti (ORCID: https://orcid.org/0009-0006-2781-6909)
- Manfredo Bruni (ORCID: https://orcid.org/0000-0001-9357-9653)
- Michela Ortoncelli (ORCID: https://orcid.org/0009-0002-6774-7080)
- M.A. Bianco (ORCID: https://orcid.org/0009-0003-9859-4475)
- Elena Pezzolo (ORCID: https://orcid.org/0000-0003-0121-4812)
- Riccardo Balestri (ORCID: https://orcid.org/0000-0002-0885-054X)
- Andrea Carugno (ORCID: https://orcid.org/0000-0002-8231-2205)
- Nicola Zerbinati (ORCID: https://orcid.org/0000-0003-2177-9677)
- Federica Veronese (ORCID: https://orcid.org/0000-0001-6438-5171)
- Caterina Foti (ORCID: https://orcid.org/0000-0001-6196-9788)
- Silvia Mariel Ferrucci (ORCID: https://orcid.org/0000-0002-6734-1366)
- Alessandra Narcisi (ORCID: https://orcid.org/0000-0002-1938-8581)
- Luca Bettolini (ORCID: https://orcid.org/0000-0003-4374-802X)
- Francesca Barei (ORCID: https://orcid.org/0000-0002-7188-7310)
- Franco Rongioletti (ORCID: https://orcid.org/0000-0002-2227-581X)
Institutions
- University of Siena (IT)
- Università Cattolica del Sacro Cuore (IT)
- University of Insubria (IT)
- University of Verona (IT)
- University of Modena and Reggio Emilia (IT)
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- University of Udine (IT)
- Vita-Salute San Raffaele University (IT)
- University of Milan (IT)
- University of Trento (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- University of L'Aquila (IT)
- Agostino Gemelli University Polyclinic (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Ospedale Santa Chiara (IT)
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
- Provincia Autonoma di Trento (IT)
- Istituto Dermopatico dell'Immacolata (IT)
- Azienda Ospedaliero Universitaria Maggiore della Carita (IT)
- Azienda Ospedaliera Ospedale Maggiore (IT)
- Ospedale Policlinico San Martino (IT)
- Ospedale San Bortolo (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- IRCCS Humanitas Research Hospital (IT)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
- University of Turin (IT)
- University of Bari Aldo Moro (IT)
- University of Naples Federico II (IT)
- University of Brescia (IT)
- University of Genoa (IT)
Publication Details
- Journal
- Antibodies
- Published
- 2025-09-03
- DOI
- https://doi.org/10.3390/antib14030075
- Citations
- 2
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 4.01